TY - JOUR
T1 - Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder
AU - Walker, Rosie
AU - Christoforou, A.
AU - Thomson, Pippa
AU - McGhee, Kevin
AU - Maclean, A.
AU - Muhleisen, T. W.
AU - Strohmaier, J.
AU - Nieratschker, V.
AU - Nothen, M. M.
AU - Rietschel, M.
AU - Cichon, S.
AU - Morris, S. W.
AU - Jilani, O.
AU - Stclair, D.
AU - Blackwood, Douglas
AU - Muir, Walter
AU - Porteous, D. J.
AU - Evans, K. L.
N1 - Jun 30
Association analysis of Neuregulin 1 candidate regions in schizophrenia and bipolar disorder
Walker, Rosie M Christoforou, Andrea Thomson, Pippa A McGhee, Kevin A Maclean, Alan Muhleisen, Thomas W Strohmaier, Jana Nieratschker, Vanessa Nothen, Markus M Rietschel, Marcella Cichon, Sven Morris, Stewart W Jilani, Omer Stclair, David Blackwood, Douglas H Muir, Walter J Porteous, David J Evans, Kathryn L Chief Scientist Office/United Kingdom Biotechnology and Biological Sciences Research Council/United Kingdom Medical Research Council/United Kingdom Research Support, Non-U.S. Gov't Ireland Neuroscience letters Neurosci Lett. 2010 Jun 30;478(1):9-13. Epub 2010 May 7.
eng
PY - 2010
Y1 - 2010
N2 - Schizophrenia (SCZ) and bipolar disorder (BPD) are severe heritable psychiatric disorders involving a complex genetic aetiology. Neuregulin 1 (NRG1) is a leading candidate gene for SCZ, and has recently been implicated in BPD. We previously reported association of two NRG1 haplotypes with SCZ and BPD in a Scottish case-control sample. One haplotype is located at the 5' end of the gene (region A), and the other is located at the 3' end (region B). Here, association to haplotypes within regions A and B was assessed in patients with SCZ and BPD in a second Scottish case-control sample and in the two Scottish samples combined. Association to region B was also assessed in patients with SCZ and BPD in a German case-control sample, and in all three samples combined. No evidence was found for association in the new samples when analysed individually; however, in the joint analysis of the two Scottish samples, a region B haplotype comprising two SNPs (rs6988339 and rs3757930) was associated with SCZ and the combined case group (SCZ: p=0.0037, OR=1.3, 95% CI: 1.1-1.6; BPD+SCZ: p=0.0080, OR=1.2, 95% CI: 1.1-1.5), with these associations withstanding multiple testing correction at the single-test level (SCZ: p(st)=0.022; BPD+SCZ: p(st)=0.044). This study supports the involvement of NRG1 variants in the less well studied 3' region in conferring susceptibility to SCZ and BPD in the Scottish population.
AB - Schizophrenia (SCZ) and bipolar disorder (BPD) are severe heritable psychiatric disorders involving a complex genetic aetiology. Neuregulin 1 (NRG1) is a leading candidate gene for SCZ, and has recently been implicated in BPD. We previously reported association of two NRG1 haplotypes with SCZ and BPD in a Scottish case-control sample. One haplotype is located at the 5' end of the gene (region A), and the other is located at the 3' end (region B). Here, association to haplotypes within regions A and B was assessed in patients with SCZ and BPD in a second Scottish case-control sample and in the two Scottish samples combined. Association to region B was also assessed in patients with SCZ and BPD in a German case-control sample, and in all three samples combined. No evidence was found for association in the new samples when analysed individually; however, in the joint analysis of the two Scottish samples, a region B haplotype comprising two SNPs (rs6988339 and rs3757930) was associated with SCZ and the combined case group (SCZ: p=0.0037, OR=1.3, 95% CI: 1.1-1.6; BPD+SCZ: p=0.0080, OR=1.2, 95% CI: 1.1-1.5), with these associations withstanding multiple testing correction at the single-test level (SCZ: p(st)=0.022; BPD+SCZ: p(st)=0.044). This study supports the involvement of NRG1 variants in the less well studied 3' region in conferring susceptibility to SCZ and BPD in the Scottish population.
UR - http://www.scopus.com/inward/record.url?scp=77953541464&partnerID=8YFLogxK
U2 - 10.1016/j.neulet.2010.04.056
DO - 10.1016/j.neulet.2010.04.056
M3 - Article
SN - 0304-3940
VL - 478
SP - 9
EP - 13
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 1
ER -